Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, September 7, 2023.
Admetsys this week won FDA breakthrough designation for its automated glucose control technology. Fast Five hosts Sean Whooley and Danielle Kirsh discuss what the glucose control system does and what executives are saying.
Moximed has implanted its first Misha knee implantable shock absorber in the U.S. Find out what an implantable shock absorber is and what doctors think about it.
GE HealthCare and Mass General are collaborating on AI algorithms to predict missed care opportunities, expanding on its existing 10-year partnership. Whooley explains the aim of the collaboration and what the artificial intelligence algorithms will be used for.
Zimmer Biomet announced several executive appointments just days after former CEO Bryan Hanson left. Tune in to discover who joins the executive team and what the new CEO says about the shuffling.
Another diabetes acquisition is in the news – this time, Abbott is acquiring Bigfoot Biomedical. The acquisition follows an established partnership between the companies. Whooley explains their prior partnership and other acquisition news in the diabetes sector.
Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.
Listen to previous episodes here.
